NCT02153944
Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety
See it on ClinicalTrials.gov ↗128 people
51.6%
48.4%
66 womenmiddle line = equal numbers62 men
- Phase
- PHASE4
- Paid for by
- National Institute of Mental Health (NIMH)
- Finished
- 2021-10-07
- Health conditions
- Anxiety Disorder
- Who could join
- Anyone
- Ages
- 18 Years – 50 Years
- Average age
- Not reported
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 49.2% · Black / African American 25% · Asian 14.1% · Not reported 6.3% · More than one race 4.7% · American Indian / Alaska Native 0.8% · Native Hawaiian / Pacific Islander 0%
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 50 Years.”
- No pregnant women
Women who were pregnant could not join.
“Pregnancy or positive pregnancy test”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Breastfeeding”
- No seizures
Women with epilepsy or past seizures were turned away.
“Any significant medical or neurological problems (e.g. cardiovascular illness, respiratory illness, neurologic illness, seizure, etc.)”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“A first-degree family history of mania, schizophrenia, or other psychoses based on verbal reports”
Study titles and rules are shown in their original English.